An observational study in Coronary Artery Bypass Grafting and Mortality, sponsored by Antalya Training and Research Hospital. Completed at 2 sites in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-08-30.
Sponsored by Antalya Training and Research Hospital · Observational
The study seeks to determine the value of CASUS in predicting mortality as compared with APACHE II scoring system among patients undergoing coronary artery bypass grafting.
Patients undergoing coronary artery bypass grafting will prospectively studied after the admission to the cardiac intensive care unit. Data on the preoperative condition, intraoperative parameters, and postoperative course will collected. CASUS and APACHE II scores will calculated on the first postoperative day. Clinical outcomes are defined as 7-day mortality, 30-day mortality and morbidity. Morbidity includes variables such as length of stay in the cardiac surgical intensive care unit and in the hospital.
Antalya Training and Research Hospital is the lead sponsor of 102 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Study population includes all adult patients who undergoing coronary artery bypass grafting during the study period.
Exclusion Criteria:
Cardiac surgery score and APACHE II will calculated on the first postoperative day.
Mortality at 7 days
Mortality in the first 7 days after surgery
Time frame: 7 days
Mortality at 30 days
Mortality in the first 30 days after surgery
Time frame: 30 days
Length of stay in the cardiac intensive care unit
Only the length of the initial stay in the cardiac intensive care unit up to 3 months
Time frame: Up to 3 months (Through study completion)
Length of the stay in the hospital
It includes the period from surgery to discharge
Time frame: Up to 3 months (Through study completion)
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Antalya Training and Research Hospital